Pear Therapeutics, Inc. (PEAR)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Pear Therapeutics, Inc. (PEAR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Pear Therapeutics, Inc. ever had a stock split?
Pear Therapeutics, Inc. Profile
| Biotechnology Industry | Healthcare Sector | Christopher D. T. Guiffre MBA CEO | NASDAQ (CM) Exchange | 704723105 CUSIP |
| US Country | 200 Employees | - Last Dividend | 10 Jun 2019 Last Split | - IPO Date |
Overview
Pear Therapeutics, Inc. is a pioneering company focused on the development and market introduction of innovative software-driven medical therapies. Established in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, and has carved a niche for itself in the realm of digital health solutions. The company is committed to addressing complex psychiatric and neurological conditions, boasting a diverse and expanding portfolio of digital products and candidates that cater to various severe health conditions. Through its unique approach, Pear Therapeutics aims to enhance patient care by integrating technology with therapeutic interventions, thereby redefining treatment paradigms in the healthcare industry.
Products and Services
- PearConnect
PearConnect serves as a comprehensive support hub designed specifically for users of Pear Therapeutics' prescription digital therapeutics. It provides resources, tools, and support to help patients maximize their treatment experience, ensuring they have access to guidance and assistance as they navigate their therapeutic journey.
- reSET
reSET is an evidence-based digital therapeutic aimed at aiding individuals in the management of substance use disorder. It incorporates cognitive behavioral therapy principles to help users develop coping skills and strategies, ultimately promoting recovery and reducing the risk of relapse.
- reSET-O
Targeting opioid use disorder specifically, reSET-O is a prescription digital therapeutic that assists patients in addressing their addiction to opioids. The platform facilitates a structured and supportive treatment experience, offering tailored interventions to help individuals achieve sustainable recovery.
- Somryst
Somryst is a digital intervention that focuses on chronic insomnia, providing users with a behavioral therapy framework aimed at improving sleep patterns and overall sleep quality. By leveraging technology, Somryst empowers patients to take control of their sleep health through engaging and effective treatment protocols.
